ライフサイエンスコーパス: warm ischemia time

1 quality of life, shorter operating time, and warm ischemia time.

2 (LPN), particularly in regards to decreased warm ischemia time.

3 system closure and hemostasis with a limited warm ischemia time.

4 transaminase, UNOS status, donor gender, and warm ischemia time.

5 also enriched in DCD donors after the first warm ischemia time.

6 kidneys, which is susceptible to changes in warm ischemia times.

7 ime, and significantly decreased with longer warm ischemia times.

8 he open group but nonsignificantly different warm ischemia times.

9 ), durations of perfusion (1 and 24 hr), and warm ischemia times (15 and 45 min).

10 me (mean, 159 vs. 188 min; P<0.001), shorter warm ischemia time (2 vs. 5 min; P<0.001) and a lower in

11 n after circulatory death (DCD, n = 36, mean warm ischemia time = 2 min) and donation after brain dea

12 sults are as follows: operative time 4.5 hr, warm ischemia time 25 min, and blood transfused (packed

13 es, estimated blood loss 344.2 +/- 690.3 mL, warm ischemia time 4.9 +/- 3.4 minutes, and donor length

14 After remaining in situ for 120 min (30-min warm ischemia time, 90-min cold ischemia time), the seco

15 The donor organ was subjected to 1 hour of warm ischemia time after circulatory cessation, then flu

16 s well as clinical factors, such as cold and warm ischemia time and HLA mismatch.

17 cases showed no significant differences for warm ischemia time and other donor outcomes, delayed gra

18 rgical demographics included operative time, warm ischemia time, and estimated blood loss.

19 Graft survival is affected by donor gender, warm ischemia time, and pretransplant patient condition.

20 um level, donor length of hospital stay, and warm ischemia time approached significance.

21 d hypothermia should be considered if longer warm ischemia times are anticipated (i.e. >25 min).

22 perform this type of anastomosis may reduce warm ischemia time as well.

23 Outcomes evaluated were operative and warm ischemia times, blood loss, donor complications, le

24 ve complications, conversions, operative and warm ischemia times, blood loss, length of hospital stay

25 nephrectomy group had shorter operative and warm ischemia times by 52 minutes (P < 0.001) and 102 se

26 status at transplantation, donor age, donor warm ischemia time (DWIT), and cold ischemia time (CIT).

27 In patients with embolization, the warm ischemia time (from embolization to removal of the

28 atients, retransplant recipients, donor age, warm ischemia time greater than 30 minutes and cold isch

29 Donor age >50 years, BMI >30, warm ischemia time >25 minutes, ITU stay >7 days and ALT

30 cCrCl <60 mL/min/1.73m, PELD >25 points, and warm ischemia time >60 minutes.

31 5 days), cold ischemia time (>10 hours), and warm ischemia time (>40 minutes).

32 last 5 years with a nearly 50% reduction of warm ischemia time in experienced hands.

33 etwork for Organ Sharing (UNOS) status, cold/warm ischemia time, intraoperative blood loss, and occur

34 cluded operative time, islet isolation time, warm ischemia time, islet equivalent (IE) counts, estima

35 onor-specific antibody, negative crossmatch, warm ischemia time less than 60 min, absence of recipien

36 and donation after brain death (DBD, n = 76, warm ischemia time = none) were collected.

37 ntified recipient BMI (P = 0.046), recipient warm ischemia time (odds ratio, OR, 1.032; 95% CI, 1.008

38 a mean estimated blood loss of 85.7 mL and a warm ischemia time of 116.0 seconds.

39 Mean warm ischemia time of the pancreas graft was 34 min.

40 may be associated with shorter operative and warm ischemia times, patients undergoing laparoscopic ne

41 sis, panel-reactive antibodies, and cold and warm ischemia time, the odds of oliguria were 1.60 (1.14

42 prove perioperative characteristics, such as warm ischemia time, to levels comparable to open surgery

43 n to asystole was 15.9+/-1.9 min and overall warm ischemia time was 12.5+/-1.0 min.

44 n, mean hospital stay was 3.2 days, and mean warm ischemia time was 123.3 seconds.

45 Mean warm ischemia time was 14.7 minutes (range, 7-40 minutes

46 The warm ischemia time was 21 minutes, and the cold ischemia

47 Mean warm ischemia time was 3 minutes after laparoscopic harv

48 let isolation time was 185 (37) minutes, and warm ischemia time was 51 (62) minutes.

49 Average warm ischemia time was 76 minutes.

50 /-0.7 vs. 3.0+/-0.7 hours, P <0.04), whereas warm ischemia time was shorter (3:55+/-1:47 vs. 4:55+/-0

51 Per minute increase in warm ischemia time was the only significant risk factor

52 hospitalization at time of OLT, and cold and warm ischemia time were independent predictors of surviv

53 Mean cold and warm ischemia times were 9:08 +/- 2:57 hr and 51 +/- 9 m

54 s, improving renal cooling or shortening the warm ischemia time will expand its indications further.

55 " such as cold ischemia time (CIT) recipient warm ischemia time (WIT) and the use of thrombolytic flu

56 ischemia time (CIT) at 2-hour intervals and warm ischemia time (WIT) at 10-minute intervals showed t

57 In the HCV+ cohort, recipient race, warm ischemia time (WIT), and diabetes also independentl